Zacks Research Research Analysts Cut Earnings Estimates for Phibro Animal Health Co. (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC) – Equities researchers at Zacks Research decreased their Q4 2024 EPS estimates for Phibro Animal Health in a research report issued to clients and investors on Wednesday, May 22nd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.35 for the quarter, down from their prior estimate of $0.37. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.13 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.36 EPS and Q3 2026 earnings at $0.33 EPS.

A number of other equities analysts have also commented on the stock. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, April 9th. Barclays raised their price objective on shares of Phibro Animal Health from $10.00 to $13.00 and gave the company an “underweight” rating in a research report on Friday, May 10th. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $14.75.

Phibro Animal Health Price Performance

PAHC stock opened at $18.55 on Friday. The firm has a 50 day moving average of $14.75 and a 200-day moving average of $12.61. The company has a current ratio of 3.16, a quick ratio of 1.67 and a debt-to-equity ratio of 1.69. Phibro Animal Health has a 12 month low of $9.40 and a 12 month high of $18.70. The firm has a market capitalization of $751.28 million, a P/E ratio of 57.97, a price-to-earnings-growth ratio of 6.11 and a beta of 0.63.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 5th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 5th. This represents a $0.48 annualized dividend and a yield of 2.59%. Phibro Animal Health’s payout ratio is presently 150.00%.

Institutional Investors Weigh In On Phibro Animal Health

A number of hedge funds have recently made changes to their positions in the business. Brandes Investment Partners LP lifted its holdings in shares of Phibro Animal Health by 13.7% in the 4th quarter. Brandes Investment Partners LP now owns 2,130,107 shares of the company’s stock worth $24,667,000 after acquiring an additional 256,807 shares during the last quarter. Acadian Asset Management LLC raised its holdings in Phibro Animal Health by 32.8% during the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock valued at $8,726,000 after buying an additional 166,776 shares during the last quarter. Brandywine Global Investment Management LLC raised its holdings in Phibro Animal Health by 21.1% during the 3rd quarter. Brandywine Global Investment Management LLC now owns 257,200 shares of the company’s stock valued at $3,284,000 after buying an additional 44,900 shares during the last quarter. Wellington Management Group LLP raised its holdings in Phibro Animal Health by 165.9% during the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after buying an additional 102,793 shares during the last quarter. Finally, Bridge City Capital LLC raised its holdings in Phibro Animal Health by 3.3% during the 1st quarter. Bridge City Capital LLC now owns 137,694 shares of the company’s stock valued at $1,780,000 after buying an additional 4,433 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.